We deliver a unique investment proposition to our investors by partnering with strategic parties to leverage the “best of both worlds”. We combine SJL’s expertise in cross-border M&A execution, operational improvements, and governance with the ability of the strategic partner to bring compelling synergies and mitigate risks.
SJL completes US$1.55 billion joint acquisition of Meridian Bioscience with SD Biosensor
SJL completes joint investment in Nexeon and NSC with SKC
SJL completes US$3.1 billion joint acquisition of Momentive Performance Materials with KCC Corporation and Wonik QnC Corporation
- SJL completes US$100 million investment into Vigevano
- SJL completes US$187 million investment into Celltrion Holdings
SJL Partners founded
What We Do
By investing together with strategic investors in Asia, we can make synergies more tangible and investment risks more controllable.
Our strength lies in finding such opportunities and realizing value from them.